Histopathological features of prostatic carcinoma in a Southwest tertiary institution in Nigeria
DOI:
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20243050Keywords:
Histopathology, Features, Prostatic carcinoma, NigeriaAbstract
Background: The diagnosis of prostatic adenocarcinoma is often straightforward, in some cases there may be benign lesions that mimic prostatic cancer histologically. This study aimed to describe the morphological features of prostatic carcinoma from laboratory specimens.
Methods: This was a retrospective study using histologically diagnosed cases of prostatic carcinoma from prostatectomy and trucut biopsy specimens. The histological sub-typing of the tumors according to WHO classification scheme of 2003 was done. The tumors were graded and scored using Gleason’s scoring scheme revised and modified at the consensus conference of the international society of urological pathology (ISUP), in 2005.
Results: Prostate cancer constituted 18.7% of all malignant tumors and 4.4% of all neoplastic diseases. The majority of cases were small acinar adenocarcinoma 275 (73.7%). Others include pseudo-hyperplastic variant 47 (12.6%), atrophic variant 35 (9.3%), foamy gland carcinoma 16 (4.2%) and signet ring/colloid carcinoma 1(0.2%). More than half were classified as well-differentiated Gleason prognostic group A tumors. There was a statistically significant association between the age of the patient and the Gleason histologic grade and the histologic grade and histologic variant p<0.05.
Conclusions: Prostatic carcinoma was thought to be a malignancy associated with elderly men but people of younger age less than fifty years are now diagnosed with the malignancy. Accurate diagnosis with the right grade and scores will go a long way in the management of the malignancy.
Metrics
References
Epstein JI, Algaba F, Allsbrook Jr WC, Bastacky S, Boccon-Gibod AM, De Marzo AM, et al. Tumours of the prostate: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. WHO of Tumours Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs, Eds JN Eble, G Sauter, JI Epstein & IA Sesterhenn. Lyon: IARC Press. 2004;163.
Adams J. The case of scirrhous carcinoma of the prostate gland with corresponding affliction of the lymphatic glands in the lumbar region and in the pelvis". Lancet. 1853;1:393.
Ivan D, The lower urinary tract and M ale reproductive Rubin’s Pathology: Clinicopathologic Foundations of Medicine, 5th edition Philadelphia Lippincott. 2008;774-77.
Ogunbiyi JO, Shittu OB. Increased incidences of prostate cancer in Nigeria J Natl Med Assoc. 1999;91(3):159-64.
Kasonde B, An overview of diagnosis and management of prostate cancer in Nigeria: Experience from the north-central state in Nigeria. Ann Afr Med. 2010;9(3):111-2.
Delongchamps NB, Singh A, Haas GP. Epidemiology of prostate cancer in Africa: another step in understanding of the disease? Curr Prabl Cancer. 2007;31(3):226-36.
Odedina FT, Ogunbiyi JO, Ukoli FA. Roots of prostate cancer in African-American men. J Natl Med Assoc. 2006;98(4):539-43.
Monitironi R, Scarpelli M, Mazzucchelli R, Cheng L, Lopez-beltran A. The spectrum of morphology in nonneoplastic prostate including cancer mimics. Histopathology. 2012;60(1):41-58.
Brimo F, Epstein JL. Immunohistochemistry pitfalls in prostate pathology. Human Pathol. 2012;43(3):313-24.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136:E359-86.
National Cancer Intelligence Network and Cancer Research, UK. Cancer Incidence and Survival by Major Ethnic Group, England. 2002-2006.
Oluwole OP, Taiwo JO, Awani KU, Adugba EO. Studies on prevalence of prostate cancer in Lokoja metropolis. AdvTrop Med Publ Health Int. 2011;2(1):15-20
Eke N, Saspira MK. Prostate cancer in Port Harcourt, Nigeria: features and outcome. Niger J Surg Res. 2002;4:34-44.
Osegbe DN. Prostatic cancer in Nigeria: facts and non facts. J Urol. 1997;157:1340-43.
Mohammed AZ, Alhassan SU, Edino ST, Ochicha O Histological review of prostatic disease in Kano, Nigeria Niger Postgrad Med J. 2003;10:1-5.
Levi AW, Epstein JL. Pseudohyperplastic prostatic adenocarcinoma on needle biopsy and simple prostatectomy. Am J Surg Pathol. 2000;24(8):1039-46.
Humphrey PA. Histological variants of prostatic carcinoma and their significance. Histopathology. 2012;60(1):59-74.
Cheville JC, Reznicek MJ, Bostwick DG. The focus of “atypical glands, suspicious for malignancy” in prostate needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol. 1997;108(6):633-40.
Brawn PN. The differentiation of prostatic carcinoma. Cancer. 1993;52(2):246-51.
Salinas CA, Tsodikov A, Ishak-Howard M,Cooney KA. Prostate cancer in young men: an important clinical entity. Nat Rev Urol. 2014;11(6):317-233.
Brawer MK, Prostate Intraepithelial Neoplasm: An Overview. J Urol. 2005;3:678-80.
Greene LF, Wheeler TM, Egawa S, Weaver RP, Scardino PT. Relationship between clinical stage and histological zone of in early prostate cancer; morphometric analysis. Br J Urol. 1999;68(5):499-509.